These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 18634145

  • 1. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis.
    Chen CH, Liao HT, Chen HA, Liang TH, Wang CT, Chou CT.
    J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145
    [Abstract] [Full Text] [Related]

  • 2. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
    Choi ST, Kang EJ, Ha YJ, Song JS.
    J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
    [Abstract] [Full Text] [Related]

  • 3. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis.
    Yasuda T, Takeyama Y, Ueda T, Shinzeki M, Sawa H, Takahiro N, Kamei K, Ku Y, Kuroda Y, Ohyanagi H.
    Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693
    [Abstract] [Full Text] [Related]

  • 4. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis.
    Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2010 Apr; 37(4):787-91. PubMed ID: 20156945
    [Abstract] [Full Text] [Related]

  • 5. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH, Huang F, Deng XH, Zhang JL, Zhang LY, Guo JH, Liang DF, Wang LS, Zhang YM.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2451-4. PubMed ID: 17156669
    [Abstract] [Full Text] [Related]

  • 6. Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease.
    Billioud V, Gibot S, Massin F, Oussalah A, Chevaux JB, Williet N, Bronowicki JP, Bigard MA, Guéant JL, Peyrin-Biroulet L.
    Dig Liver Dis; 2012 Jun 19; 44(6):466-70. PubMed ID: 22341488
    [Abstract] [Full Text] [Related]

  • 7. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis.
    Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G, Stohl W.
    Ann Rheum Dis; 2009 Nov 19; 68(11):1768-74. PubMed ID: 19054829
    [Abstract] [Full Text] [Related]

  • 8. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT.
    Rheumatology (Oxford); 2006 Apr 19; 45(4):414-20. PubMed ID: 16287916
    [Abstract] [Full Text] [Related]

  • 9. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis.
    Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M.
    J Crit Care; 2010 Jun 19; 25(2):362.e1-6. PubMed ID: 19914031
    [Abstract] [Full Text] [Related]

  • 10. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS, Park JJ, Kim SW, Hong SP, Kim TI, Kim WH, Cheon JH.
    Dig Liver Dis; 2012 Nov 19; 44(11):897-903. PubMed ID: 22721842
    [Abstract] [Full Text] [Related]

  • 11. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH, Lee HJ, Sung IH, Kim TH.
    J Rheumatol; 2007 Aug 19; 34(8):1753-9. PubMed ID: 17610317
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma.
    Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, Kotzampassi K.
    J Trauma; 2008 Dec 19; 65(6):1385-90. PubMed ID: 19077631
    [Abstract] [Full Text] [Related]

  • 13. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies.
    Karapanagiotou EM, Pelekanou E, Charpidou A, Tsaganos T, Anagnostou V, Plachouras D, Giamarellos-Bourboulis EJ, Syrigos KN.
    Anticancer Res; 2008 Dec 19; 28(2B):1411-5. PubMed ID: 18505088
    [Abstract] [Full Text] [Related]

  • 14. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease.
    Rohde G, Radsak MP, Borg I, Buhl R, Schultze-Werninghaus G, Taube C.
    Respiration; 2012 Dec 19; 83(2):133-9. PubMed ID: 21701149
    [Abstract] [Full Text] [Related]

  • 15. Serum sTREM-1 (soluble triggering receptor expressed on myeloid cells-1) associates negatively with embryo quality in infertility patients.
    Haller-Kikkatalo K, Sarapik A, Faure GC, Béné MC, Massin F, Salumets A, Uibo R.
    Am J Reprod Immunol; 2012 Jul 19; 68(1):68-74. PubMed ID: 22229451
    [Abstract] [Full Text] [Related]

  • 16. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
    Myles A, Viswanath V, Singh YP, Aggarwal A.
    J Rheumatol; 2011 Sep 19; 38(9):1994-9. PubMed ID: 21724696
    [Abstract] [Full Text] [Related]

  • 17. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis.
    Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H.
    Crit Care; 2006 Sep 19; 10(6):R166. PubMed ID: 17129388
    [Abstract] [Full Text] [Related]

  • 18. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema.
    Bishara J, Goldberg E, Ashkenazi S, Yuhas Y, Samra Z, Saute M, Shaked H.
    Ann Thorac Surg; 2009 Jan 19; 87(1):251-4. PubMed ID: 19101307
    [Abstract] [Full Text] [Related]

  • 19. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
    Tejera A, Santolaria F, Diez ML, Alemán-Valls MR, González-Reimers E, Martínez-Riera A, Milena-Abril A.
    Cytokine; 2007 Jun 19; 38(3):117-23. PubMed ID: 17659879
    [Abstract] [Full Text] [Related]

  • 20. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.
    Park MC, Lee SW, Choi ST, Park YB, Lee SK.
    Scand J Rheumatol; 2007 Jun 19; 36(2):101-6. PubMed ID: 17476615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.